Symptom Management Implementation of Patient Reported Outcomes in Oncology
Public ClinicalTrials.gov record NCT03850912. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
SIMPRO Research Center: Integration and Implementation of PROs for Symptom Management in Oncology Practice
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Deficits in the management of common symptoms cause substantial morbidity for cancer patients.Because the health care delivery system is structured to be reactive and not proactive, there are missed opportunities to optimize symptom control. Growth in Internet access and proliferation of smartphones has created an opportunity to re-engineer cancer care delivery. Electronic symptom tracking and feedback is a promising strategy to improve symptom control. Electronic patient reported outcome (ePRO) monitoring of cancer symptoms has been shown to decrease symptom burden, improve quality of life, reduce acute care and even extend survival. SIMPRO will use functioning ePRO prototypes to create and refine the electronic symptom management system eSyM
Study identification
- NCT ID
- NCT03850912
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Not applicable
- Enrollment
- 42,808 participants
Conditions and interventions
Interventions
- Stakeholder Survey (Control Period) Other
- Stakeholder Survey (Intervention Period) Other
- Qualitative Interview Other
- SASS Questionnaire Other
- eSyM Other
Other
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 25, 2019 (Actual)
- Primary completion
- Mar 31, 2023 (Actual)
- Completion
- Jun 9, 2025 (Actual)
- Last update posted
- Aug 27, 2025
2019 – 2025
United States locations
- U.S. sites
- 6
- U.S. states
- 6
- U.S. cities
- 6
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Maine Medical Center | Portland | Maine | 04101 | — |
| Dana Farber Cancer Institute | Boston | Massachusetts | 02115 | — |
| Dartmouth-Hitchcock Medical Center | Lebanon | New Hampshire | 03756 | — |
| Brown University Health (formerly Lifespan Cancer Institute) | Providence | Rhode Island | 02905 | — |
| Baptist Memoiral HealthCare | Memphis | Tennessee | 38120 | — |
| West Virginia University Medical Center | Morgantown | West Virginia | 26506 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03850912, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 27, 2025 · Synced Oct 17, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT03850912 live on ClinicalTrials.gov.